| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Casdin Capital | - | Yes | - | Detail |
| Redmile Group | - | Yes | - | Detail |
| aMoon Fund | - | - | - | Detail |
| ArrowMark Partners | - | - | - | Detail |
| D1 Capital Partners | - | - | - | Detail |
| Fidelity Management and Research Company | - | - | - | Detail |
| Helicase Venture | - | - | - | Detail |
| Irving Investors | - | - | - | Detail |
| Perceptive Advisors | - | - | - | Detail |
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| May 30, 2018 | Series C | $ 12M | AGC,Corporation Ventures,etc. | Detail |
| Feb 22, 2021 | Corporate Round | 0 | Merck Global Health Innovation Fund | Detail |
| Dec 7, 2019 | Debt Financing | $ 5M | Detail | |
| Jan 1, 2013 | Seed | 0 | Detail | |
| Feb 2, 2016 | Series A | $ 5.10M | Oregon Venture Fund,Phoenix Venture Partners,etc. | Detail |
| Jan 7, 2019 | Series D | $ 10.36M | JSR Corp,KBI Biopharma | Detail |
| Aug 14, 2017 | Series B | 0 | Phoenix Venture Partners | Detail |
| Jan 14, 2020 | Series D | $ 10.40M | Columbia Ventures,JSR Life Sciences,etc. | Detail |
| Oct 20, 2020 | Series E | $ 69.99M | ArrowMark Partners,Casdin Capital,etc. | Detail |